| Year |
Citation |
Score |
| 2023 |
Zhou G, Zhang W, Wen H, Su Q, Hao Z, Liu J, Gao Y, Zhang H, Ge B, Tong C, He X, Wang X. Esculetin improves murine mastitis induced by streptococcus isolated from bovine mammary glands by inhibiting NF-κB and MAPK signaling pathways. Microbial Pathogenesis. 185: 106393. PMID 37852550 DOI: 10.1016/j.micpath.2023.106393 |
0.303 |
|
| 2023 |
Liu J, Zhang Q, Wang J, Wang C, Lan T, Wang T, Wang B. Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer. International Journal of Molecular Sciences. 24. PMID 37762705 DOI: 10.3390/ijms241814402 |
0.306 |
|
| 2023 |
Pu X, Xu C, Wang Q, Wang W, Wu F, Cai X, Song Z, Yu J, Zhong W, Wang Z, Zhang Y, Liu J, Zhang S, Liu A, Li W, et al. Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China. Thoracic Cancer. PMID 37718634 DOI: 10.1111/1759-7714.15105 |
0.302 |
|
| 2023 |
Wu Z, Qu B, Yuan M, Liu J, Zhou C, Sun M, Guo Z, Zhang Y, Song Y, Wang Z. CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2303246. PMID 37409440 DOI: 10.1002/advs.202303246 |
0.304 |
|
| 2023 |
Fan G, Li D, Liu J, Tao N, Meng C, Cui J, Cai J, Sun T. HNRNPD is a prognostic biomarker in non-small cell lung cancer and affects tumor growth and metastasis via the PI3K-AKT pathway. Biotechnology & Genetic Engineering Reviews. 1-20. PMID 36971333 DOI: 10.1080/02648725.2023.2196155 |
0.301 |
|
| 2022 |
Liu J, Jing W, Wang T, Hu Z, Lu H. Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer. Pharmacological Research. 106554. PMID 36379357 DOI: 10.1016/j.phrs.2022.106554 |
0.315 |
|
| 2022 |
Roussel MF, Jonchere B, Williams J, Zindy F, Liu J, Robinson S, Farmer DM, Min J, Yang L, Stripay JL, Wang Y, Freeman BB, Yu J, Shelat AA, Rankovic Z. Combination of ribociclib with BET-bromodomain and PI3K/mTOR inhibitors for medulloblastoma treatment in vitro and in vivo. Molecular Cancer Therapeutics. PMID 36318650 DOI: 10.1158/1535-7163.MCT-21-0896 |
0.304 |
|
| 2022 |
Pribnow A, Jonchere B, Liu J, Smith KS, Campagne O, Xu K, Robinson S, Patel Y, Onar-Thomas A, Wu G, Stewart CF, Northcott PA, Yu J, Robinson GW, Roussel MF. Combination of ribociclib and gemcitabine for the treatment of medulloblastoma. Molecular Cancer Therapeutics. PMID 35709750 DOI: 10.1158/1535-7163.MCT-21-0598 |
0.308 |
|
| 2022 |
Zhao F, Li S, Liu J, Wang J, Yang B. Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression. Human Cell. PMID 35676608 DOI: 10.1007/s13577-022-00725-1 |
0.302 |
|
| 2021 |
Liu J, You M, Yao Y, Ji C, Wang Z, Wang F, Wang D, Qi Z, Yu G, Sun Z, Guo W, Liu J, Li S, Jin Y, Zhao T, et al. SRSF1 plays a critical role in invariant natural killer T cell development and function. Cellular & Molecular Immunology. PMID 34522020 DOI: 10.1038/s41423-021-00766-w |
0.304 |
|
| 2021 |
Zhao S, Geng Y, Cao L, Yang Q, Pan T, Zhou D, Liu J, Shi Z, Zhang J. Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway. American Journal of Cancer Research. 11: 2142-2158. PMID 34094674 |
0.306 |
|
| 2021 |
Cao L, Zhao S, Yang Q, Shi Z, Liu J, Pan T, Zhou D, Zhang J. Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer. Frontiers in Oncology. 11: 614458. PMID 33738256 DOI: 10.3389/fonc.2021.614458 |
0.303 |
|
| 2020 |
Shao J, Jiang F, Hu M, Mei E, Pan Z, Chen C, Lin L, Zheng T, Cai W, Li Z, Liu J. The role of FOS-mediated autophagy activation in the indocyanine green-based photodynamic therapy for treating melanoma. Journal of Photochemistry and Photobiology. B, Biology. 214: 112101. PMID 33316624 DOI: 10.1016/j.jphotobiol.2020.112101 |
0.303 |
|
| 2020 |
Wang KJ, Zhang WQ, Liu JJ, Cui Y, Cui JZ. Piceatannol protects against cerebral ischemia/reperfusion‑induced apoptosis and oxidative stress via the Sirt1/FoxO1 signaling pathway. Molecular Medicine Reports. PMID 33173979 DOI: 10.3892/mmr.2020.11618 |
0.301 |
|
| 2020 |
Liu J, Liu X, Wu M, Qi G, Liu B. Engineering Living Mitochondria with AIE Photosensitizer for Synergistic Cancer Cell Ablation. Nano Letters. PMID 32969665 DOI: 10.1021/acs.nanolett.0c02778 |
0.309 |
|
| 2020 |
Li H, Liu Y, Liu X, Zhao D, Liu J, Cheng Y. A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer. Anti-Cancer Drugs. PMID 32694423 DOI: 10.1097/CAD.0000000000000969 |
0.309 |
|
| 2020 |
Liu J, Luo X, Guo R, Jing W, Lu H. Cell metabolomics reveal berberine inhibited pancreatic cancer cell viability and metastasis by regulating citrate metabolism. Journal of Proteome Research. PMID 32692565 DOI: 10.1021/acs.jproteome.0c00394 |
0.31 |
|
| 2020 |
Cai FY, Yao XM, Jing M, Kong L, Liu JJ, Fu M, Liu XZ, Zhang L, He SY, Li XT, Ju RJ. Enhanced antitumor efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition. Journal of Liposome Research. 1-43. PMID 32200703 DOI: 10.1080/08982104.2020.1745831 |
0.305 |
|
| 2020 |
Yang J, Lian Y, Yang R, Lian Y, Wu J, Liu J, Wang K, Xu H. Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes. Molecular Therapy. Nucleic Acids. 19: 1164-1175. PMID 32059342 DOI: 10.1016/j.omtn.2019.12.041 |
0.308 |
|
| 2019 |
Liu J, Liang H, Chen C, Wang X, Qu F, Wang H, Yang K, Wang Q, Zhao N, Meng J, Gao A. Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells. Bioscience Reports. PMID 31755894 DOI: 10.1042/BSR20192489 |
0.301 |
|
| 2019 |
Pan T, Zhou D, Shi Z, Qiu Y, Zhou G, Liu J, Yang Q, Cao L, Zhang J. Centromere Protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2. Cancer Letters. PMID 31705927 DOI: 10.1016/j.canlet.2019.11.003 |
0.308 |
|
| 2019 |
Hu M, Chen C, Liu J, Cai L, Shao J, Chen Z, Lin L, Zheng T, Ding X, Li Z. The melanogenic effects and underlying mechanism of paeoniflorin in human melanocytes and vitiligo mice. Fitoterapia. 104416. PMID 31704261 DOI: 10.1016/j.fitote.2019.104416 |
0.312 |
|
| 2019 |
Li H, Du H, Zhang G, Wu Y, Qiu P, Liu J, Guo J, Liu X, Sun L, Du B, Tan Y. Curcumin plays a synergistic role in combination with HSV-TK/GCV in inhibiting growth of murine B16 melanoma cells and melanoma xenografts. Peerj. 7: e7760. PMID 31579620 DOI: 10.7717/peerj.7760 |
0.3 |
|
| 2018 |
Wang Y, Cui P, Liu J, Wu H, Ma J. Aclidinium bromide inhibits the growth and metastasis of gastric cancer MKN‑28 cells via the PI3K signaling pathway. Molecular Medicine Reports. PMID 29956761 DOI: 10.3892/mmr.2018.9220 |
0.311 |
|
| 2018 |
Cui Z, Li D, Liu J, Zhang Y, Xu H, Yin H, Li H, Wang G, Cai H, Zhang L, Duan S, Jiang H. G‑protein‑coupled receptor 120 regulates the development and progression of human esophageal cancer. Oncology Reports. PMID 29901155 DOI: 10.3892/or.2018.6470 |
0.316 |
|
| 2017 |
Liu J, He Y, Zhang D, Cai Y, Zhang C, Zhang P, Zhu H, Xu N, Liang S. In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells. Molecular Medicine Reports. PMID 28677760 DOI: 10.3892/mmr.2017.6879 |
0.311 |
|
| 2016 |
Lu W, Wang X, Liu J, He Y, Liang Z, Xia Z, Cai Y, Zhou L, Zhu H, Liang S. Downregulation of ARHGDIA contributes to human glioma progression through activation of Rho GTPase signaling pathway. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 27726098 DOI: 10.1007/s13277-016-5374-6 |
0.3 |
|
| 2016 |
Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, Zhang P, Zhu H, Xu N, Liang S. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. PMID 27662663 DOI: 10.18632/oncotarget.12147 |
0.305 |
|
| 2016 |
Shi X, Liu J, Yang T, Zhang Y, Li T, Chen J. TLR2/NFκB signalling regulates endogenous IL-6 release from marrow-derived mesenchymal stromal cells to suppress the apoptosis of PC12 cells injured by oxygen and glucose deprivation. Molecular Medicine Reports. PMID 27108485 DOI: 10.3892/mmr.2016.5158 |
0.302 |
|
| 2015 |
Chen Y, Huang Y, Cui Z, Liu J. Purification, characterization and biological activity of a novel polysaccharide from Inonotus obliquus. International Journal of Biological Macromolecules. 79: 587-94. PMID 26026982 DOI: 10.1016/j.ijbiomac.2015.05.016 |
0.302 |
|
| 2015 |
Ren X, Zheng D, Guo F, Liu J, Zhang B, Li H, Tian W. PPARγ suppressed Wnt/β-catenin signaling pathway and its downstream effector SOX9 expression in gastric cancer cells. Medical Oncology (Northwood, London, England). 32: 91. PMID 25720524 DOI: 10.1007/s12032-015-0536-8 |
0.3 |
|
| 2014 |
Gotoh T, Vila-Caballer M, Santos CS, Liu J, Yang J, Finkielstein CV. The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells. Molecular Biology of the Cell. 25: 3081-93. PMID 25103245 DOI: 10.1091/mbc.E14-05-0993 |
0.303 |
|
| 2013 |
Liu Y, Zhang X, Liu J, Hou G, Zhang S, Zhang J. Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 1275-86. PMID 24014089 DOI: 10.1007/s13277-013-1170-8 |
0.302 |
|
| 2012 |
Zhu Y, Zhang X, Liu Y, Zhang S, Liu J, Ma Y, Zhang J. Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 33: 1349-62. PMID 22492237 DOI: 10.1007/s13277-012-0383-6 |
0.302 |
|
| Show low-probability matches. |